Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 10/2009

01.10.2009 | Original Paper

APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations

verfasst von: Per Arne Andresen, Ketil Heimdal, Kristin Aaberg, Kristin Eklo, Sarah Ariansen, Alexandra Silye, Olav Fausa, Lars Aabakken, Stefan Aretz, Tor J. Eide, Tobias Gedde-Dahl Jr.

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease caused by mutations in the adenomatous polyposis coli (APC) gene. Massive formation of colorectal adenomas, of which some will inevitably develop into adenocarcinomas, is the hallmark of the disease. Characterization of causative APC mutations allows presymptomatic diagnosis, close follow-up and prophylactic intervention in families. To date more than 900 different germline mutations have been characterized worldwide demonstrating allelic heterogeneity.

Purpose

The germline mutation spectrum of APC identified in 69 apparently unrelated Norwegian FAP families are presented and discussed with reference to clinical phenotype and novel mutation rate.

Methods

Different methods have been used over the years. However, all mutations were confirmed detectable by an implemented denaturing high-performance liquid chromatography screening approach. Multiplex ligation-dependent probe amplification analysis was employed for potential gross rearrangements.

Results

Fifty-three distinctive mutations were detected, of which 22 have been detected in Norway exclusively. Except for two major deletion mutations encompassing the entire APC, all mutations resulted in premature truncation of translation caused by non-sense (31%) or change in reading frame (69%).

Conclusion

A high ratio of novel APC mutations continues to contribute to APC mutation heterogeneity causing FAP. This is the first comprehensive report of APC germline mutation spectrum in Norway.
Literatur
Zurück zum Zitat Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Moslein G, Schulmann K, Propping P, Friedl W (2004) Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat 24:370–380. doi:10.1002/humu.20087 CrossRefPubMed Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Moslein G, Schulmann K, Propping P, Friedl W (2004) Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat 24:370–380. doi:10.​1002/​humu.​20087 CrossRefPubMed
Zurück zum Zitat Azzopardi D, Dallosso AR, Eliason K, Hendrickson BC, Jones N, Rawstorne E, Colley J, Moskvina V, Frye C, Sampson JR, Wenstrup R, Scholl T, Cheadle JP (2008) Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res 68:358–363. doi:10.1158/0008-5472.CAN-07-5733 CrossRefPubMed Azzopardi D, Dallosso AR, Eliason K, Hendrickson BC, Jones N, Rawstorne E, Colley J, Moskvina V, Frye C, Sampson JR, Wenstrup R, Scholl T, Cheadle JP (2008) Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res 68:358–363. doi:10.​1158/​0008-5472.​CAN-07-5733 CrossRefPubMed
Zurück zum Zitat Bennett RR, den Dunnen J, O’Brien KF, Darras BT, Kunkel LM (2001) Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2:17 Epub Oct 17CrossRefPubMed Bennett RR, den Dunnen J, O’Brien KF, Darras BT, Kunkel LM (2001) Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2:17 Epub Oct 17CrossRefPubMed
Zurück zum Zitat Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlstrom J, Martinsson T, Nordling M, Hultcrantz R (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121:1127–1135. doi:10.1053/gast.2001.28707 CrossRefPubMed Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlstrom J, Martinsson T, Nordling M, Hultcrantz R (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121:1127–1135. doi:10.​1053/​gast.​2001.​28707 CrossRefPubMed
Zurück zum Zitat De Rosa M, Dourisboure RJ, Morelli G, Graziano A, Gutiérrez A, Thibodeau S, Halling K, Avila KC, Duraturo F, Podesta EJ, Izzo P, Solano AR (2004) First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations. Hum Mutat 23:523–524. doi:10.1002/humu.9237 CrossRefPubMed De Rosa M, Dourisboure RJ, Morelli G, Graziano A, Gutiérrez A, Thibodeau S, Halling K, Avila KC, Duraturo F, Podesta EJ, Izzo P, Solano AR (2004) First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations. Hum Mutat 23:523–524. doi:10.​1002/​humu.​9237 CrossRefPubMed
Zurück zum Zitat Enomoto M, Konishi M, Iwama T, Utsunomiya J, Sugihara KI, Miyaki M (2000) The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 30:82–88. doi:10.1093/jjco/hyd017 CrossRefPubMed Enomoto M, Konishi M, Iwama T, Utsunomiya J, Sugihara KI, Miyaki M (2000) The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 30:82–88. doi:10.​1093/​jjco/​hyd017 CrossRefPubMed
Zurück zum Zitat Fodde R, van der Luijt R, Wijnen J, Tops C, van der Klift H, van Leeuwen-Cornelisse I, Griffioen G, Vasen H, Khan PM (1992) Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics 13:1162–1168. doi:10.1016/0888-7543(92)90032-N CrossRefPubMed Fodde R, van der Luijt R, Wijnen J, Tops C, van der Klift H, van Leeuwen-Cornelisse I, Griffioen G, Vasen H, Khan PM (1992) Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics 13:1162–1168. doi:10.​1016/​0888-7543(92)90032-N CrossRefPubMed
Zurück zum Zitat Friedl W, Aretz S (2005) Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients. Hered Cancer Clin Pract 3:95–114 Friedl W, Aretz S (2005) Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients. Hered Cancer Clin Pract 3:95–114
Zurück zum Zitat Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, Kadmon M, Wolf M, Fahnenstich J, Gebert J, Moslein G, Mangold E, Propping P (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521. doi:10.1136/gut.48.4.515 CrossRefPubMed Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, Kadmon M, Wolf M, Fahnenstich J, Gebert J, Moslein G, Mangold E, Propping P (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521. doi:10.​1136/​gut.​48.​4.​515 CrossRefPubMed
Zurück zum Zitat García-Lozano JR, Cordero C, Fernández-Suárez A, Encarnación M, Pizarro A, Núñez-Roldán A (2005) APC germ-line mutations in southern Spanish patients with familial adenomatous polyposis: genotype–phenotype correlations and identification of eight novel mutations. Genet Test 9:37–40. doi:10.1089/gte.2005.9.37 CrossRefPubMed García-Lozano JR, Cordero C, Fernández-Suárez A, Encarnación M, Pizarro A, Núñez-Roldán A (2005) APC germ-line mutations in southern Spanish patients with familial adenomatous polyposis: genotype–phenotype correlations and identification of eight novel mutations. Genet Test 9:37–40. doi:10.​1089/​gte.​2005.​9.​37 CrossRefPubMed
Zurück zum Zitat Gavert N, Yaron Y, Naiman T, Bercovich N, Rozen P, Shomrat R, Legum C, Orr-Urtreger A (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat 19:664 MIB#508CrossRefPubMed Gavert N, Yaron Y, Naiman T, Bercovich N, Rozen P, Shomrat R, Legum C, Orr-Urtreger A (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat 19:664 MIB#508CrossRefPubMed
Zurück zum Zitat Gedde-Dahl T Jr, Heim S, Lothe R, Bye R, Brevik K, Geitvik GA, Kyrkjebo HT, Hognestad J, Nygaard K, Bergan A, Olaisen B, Kildal S, Svanes KH (1988) The polyposis project. Tidsskr Nor Laegeforen 108:2465–2468 Article in NorwegianPubMed Gedde-Dahl T Jr, Heim S, Lothe R, Bye R, Brevik K, Geitvik GA, Kyrkjebo HT, Hognestad J, Nygaard K, Bergan A, Olaisen B, Kildal S, Svanes KH (1988) The polyposis project. Tidsskr Nor Laegeforen 108:2465–2468 Article in NorwegianPubMed
Zurück zum Zitat Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderahim H, Cohen D, Leppert M, White R (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600. doi:10.1016/0092-8674(81)90021-0 CrossRefPubMed Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderahim H, Cohen D, Leppert M, White R (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600. doi:10.​1016/​0092-8674(81)90021-0 CrossRefPubMed
Zurück zum Zitat Kanter-Smoler G, Fritzell K, Rohlin A, Engwall Y, Hallberg B, Bergman A, Meuller J, Grönberg H, Karlsson P, Björk J, Nordling M (2008) Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Med 6:10. doi:10.1186/1741-7015-6-10 CrossRefPubMed Kanter-Smoler G, Fritzell K, Rohlin A, Engwall Y, Hallberg B, Bergman A, Meuller J, Grönberg H, Karlsson P, Björk J, Nordling M (2008) Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Med 6:10. doi:10.​1186/​1741-7015-6-10 CrossRefPubMed
Zurück zum Zitat Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, Mc Kechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y (1991) Identification of FAP locus gene from chromosome 5q21. Science 253:661–665. doi:10.1126/science.1651562 CrossRefPubMed Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, Mc Kechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y (1991) Identification of FAP locus gene from chromosome 5q21. Science 253:661–665. doi:10.​1126/​science.​1651562 CrossRefPubMed
Zurück zum Zitat Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton SR, Kinzler KW, Vogelstein B, Nakamura Y (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456. doi:10.1073/pnas.89.10.4452 CrossRefPubMed Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton SR, Kinzler KW, Vogelstein B, Nakamura Y (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456. doi:10.​1073/​pnas.​89.​10.​4452 CrossRefPubMed
Zurück zum Zitat Norheim Andersen S, Lovig T, Fausa O, Rognum TO (1999) Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis. Scand J Gastroenterol 34:611–617. doi:10.1080/003655299750026083 CrossRefPubMed Norheim Andersen S, Lovig T, Fausa O, Rognum TO (1999) Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis. Scand J Gastroenterol 34:611–617. doi:10.​1080/​0036552997500260​83 CrossRefPubMed
Zurück zum Zitat Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ, Thomas G (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127. doi:10.1073/pnas.94.22.12122 CrossRefPubMed Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ, Thomas G (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127. doi:10.​1073/​pnas.​94.​22.​12122 CrossRefPubMed
Zurück zum Zitat Vandrovcova J, Stekrova J, Kebrdlova V, Kohoutova M (2004) Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations. Hum Mutat 23:397 MIB#695CrossRefPubMed Vandrovcova J, Stekrova J, Kebrdlova V, Kohoutova M (2004) Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations. Hum Mutat 23:397 MIB#695CrossRefPubMed
Zurück zum Zitat Wallis YL, Morton DG, McKeown CM, Macdonald F (1999) Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet 36:14–20PubMed Wallis YL, Morton DG, McKeown CM, Macdonald F (1999) Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet 36:14–20PubMed
Zurück zum Zitat Wu G, Wu W, Hegde M, Fawkner M, Chong B, Love D, Su LK, Lynch P, Snow K, Richards CS (2001) Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography. Genet Test 5:281–290. doi:10.1089/109065701753617408 CrossRefPubMed Wu G, Wu W, Hegde M, Fawkner M, Chong B, Love D, Su LK, Lynch P, Snow K, Richards CS (2001) Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography. Genet Test 5:281–290. doi:10.​1089/​1090657017536174​08 CrossRefPubMed
Metadaten
Titel
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
verfasst von
Per Arne Andresen
Ketil Heimdal
Kristin Aaberg
Kristin Eklo
Sarah Ariansen
Alexandra Silye
Olav Fausa
Lars Aabakken
Stefan Aretz
Tor J. Eide
Tobias Gedde-Dahl Jr.
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 10/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0594-4

Weitere Artikel der Ausgabe 10/2009

Journal of Cancer Research and Clinical Oncology 10/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.